Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.

MLA

Koki Nojiri, et al. “Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.” Molecular & Cellular Biology, vol. 41, no. 10, Oct. 2021, pp. 1–18. EBSCOhost, https://doi.org/10.1128/MCB.00352-21.

APA

Koki Nojiri, Shuhei Fudetani, Ayami Arai, Takuya Kitamura, Takayuki Sassa, & Akio Kihara. (2021). Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome. Molecular & Cellular Biology, 41(10), 1–18. https://doi.org/10.1128/MCB.00352-21

Chicago

Koki Nojiri, Shuhei Fudetani, Ayami Arai, Takuya Kitamura, Takayuki Sassa, and Akio Kihara. 2021. “Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.” Molecular & Cellular Biology 41 (10): 1–18. doi:10.1128/MCB.00352-21.